ResMed (ASX:RMD) Result Analyst Comments: Reporting Season, August 2023

from Morgans Financial Limited (Imports from Soundcloud) · host Morgans Financial Limited

Morgans Senior Analyst Dr Derek Jellinek gives an update on ResMed's mixed 4Q, as strong sales across all product lines failed to translate into operating leverage. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.facebook.com/MorgansAU On Instagram: www.instagram.com/Morgans.Australia On Twitter: twitter.com/MorgansAU

Episode metadata supplied by the publisher feed · Published Aug 7, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

ResMed (ASX:RMD) Result Analyst Comments: Reporting Season, August 2023

0:00 6:41

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Morgans Financial Limited (Imports from Soundcloud)?

This episode is 6 minutes long.

When was this Morgans Financial Limited (Imports from Soundcloud) episode published?

This episode was published on August 7, 2023.

Can I download this Morgans Financial Limited (Imports from Soundcloud) episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!